Abstract
In order to identify new active drug candidates against cancer diseases we investigated the tumor cell growth inhibition, formation of reactive oxygen species, mitochondrial membrane damage, cell cycle arrest and DNA binding activity of a new bis(triethylammonium) tris[1,1-bis(indol-3-yl)-1-(3,4-catecholate)methane]vanadate(IV) complex. It exhibited significant antiproliferative activity against various cancer cell lines, showed a stronger DNA binding than cisplatin and led to mitochondrial damage, a formation of reactive oxygen species, and a cell cycle arrest in the G2/M phase of cancer cells.
Keywords:
Anticancer drugs; DNA binding; Diindolylmethane; Reactive oxygen species; Vanadium.
Copyright © 2019 Elsevier Inc. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antineoplastic Agents / chemical synthesis
-
Antineoplastic Agents / pharmacology*
-
Catechols / chemical synthesis
-
Catechols / pharmacology*
-
Cell Line, Tumor
-
Cell Proliferation / drug effects
-
Coordination Complexes / chemical synthesis
-
Coordination Complexes / pharmacology*
-
DNA / drug effects
-
Drug Screening Assays, Antitumor
-
G2 Phase Cell Cycle Checkpoints / drug effects
-
Humans
-
Indoles / chemical synthesis
-
Indoles / pharmacology*
-
Ligands
-
Male
-
Membrane Potential, Mitochondrial / drug effects
-
Mitochondria / drug effects
-
Reactive Oxygen Species / metabolism
-
Salmon
-
Vanadium / chemistry
Substances
-
Antineoplastic Agents
-
Catechols
-
Coordination Complexes
-
Indoles
-
Ligands
-
Reactive Oxygen Species
-
Vanadium
-
DNA
-
3,3'-diindolylmethane